1: J Orthop Trauma. 2002 May;16(5):345-6.  Fluorescent tetracycline labeling as an aid to debridement of necrotic bone inthe treatment of chronic osteomyelitis.Dahners LE, Bos GD.Department of Orthopaedics, University of North Carolina, Campus Box 7055,Chapel Hill, NC 27599, USA.The authors have found that several months of preoperative tetracyclineadministration will label living bone so that it fluoresces under a blacklightduring surgery. This allows intraoperative differentiation of viable bone fromnecrotic sequestra, which require removal in the treatment of chronic boneinfection.PMID: 11972078 [PubMed - indexed for MEDLINE]